GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biotika AS (XBRA:1BSL01AE) » Definitions » Institutional Ownership

Biotika AS (XBRA:1BSL01AE) Institutional Ownership : 5.76% (As of Jun. 19, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Biotika AS Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Biotika AS's institutional ownership is 5.76%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Biotika AS's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Biotika AS's Float Percentage Of Total Shares Outstanding is 0.00%.


Biotika AS Institutional Ownership Historical Data

The historical data trend for Biotika AS's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotika AS Institutional Ownership Chart

Biotika AS Historical Data

The historical data trend for Biotika AS can be seen below:

2015-01-31 2015-02-28 2015-03-31 2015-04-30 2015-05-31 2015-06-30 2015-07-31 2015-08-31 2015-09-30 2015-10-31
Institutional Ownership 5.76 5.76 5.76 5.76 5.76 5.76 5.76 5.76 5.76 5.76

Biotika AS Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Biotika AS (XBRA:1BSL01AE) Business Description

Traded in Other Exchanges
N/A
Address
Slovenskc Lupca 566, Banská Bystrica, SVK, 976 13
Biotika AS is a manufacturer of pharmaceutical preparations for the human and veterinary application. It is engaged in the production of Active Pharmaceutical Ingredients (API), contract manufacturing of API, and contract manufacturing of final dosage formulations. It also offers research and development services. It manufacturers Polymyxine B Sulfate and other API for third parties (toll manufacturing) of pharmaceutical quality. Biotika is well known as a reliable manufacturer of high-quality pharmaceutical preparations for the human as well as veterinary application and also as a very important producer of the feed additives for breeding farm animals.

Biotika AS (XBRA:1BSL01AE) Headlines

No Headlines